Status:
COMPLETED
Effectiveness of WhatsApp Online Group Discussion for Smoking Relapse Prevention
Lead Sponsor:
The University of Hong Kong
Conditions:
Smoking Cessation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to examine the effectiveness and cost-effectiveness of WhatsApp group discussion for smoking relapse prevention. To assess the effect due to treatment modality through the WhatsApp soc...
Detailed Description
Study design: This is a 2-arm open-labelled pragmatic randomized controlled trial, by comparing the 12-month tobacco abstinence between the recent quitters who will join WhatsApp group discussion (In...
Eligibility Criteria
Inclusion
- Daily tobacco user before service intake
- Aged 18 years or above
- Have enrolled or re-enrolled in the smoking cessation treatment for no more than 8 weeks
- Not using tobacco products (including traditional cigarettes and heat-not-burn tobacco products) for 3 to 30 days
- Able to communicate in Cantonese/Mandarin and read Chinese
- Have a smart phone with local network connection
Exclusion
- Do not use WhatsApp as communication tool and show no interest to use WhatsApp
- Have unstable physical or psychological conditions as advised by doctors or counsellor in charge
- Have become pregnant in the past 2 months
Key Trial Info
Start Date :
October 4 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
928 Patients enrolled
Trial Details
Trial ID
NCT03760224
Start Date
October 4 2018
End Date
June 30 2021
Last Update
July 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hong Kong University
Hong Kong, Hong Kong